MAITI, Animesh et al. The BRIDGE-DS Study: Improved Glycemic Control and Renal Function in Type 2 Diabetes Mellitus Patients Using the Fixed-Dose Combination of Dapagliflozin and Sitagliptin. Journal of Endocrinology & Metabolism, [S. l.], v. 15, n. 4, p. 153–160, 2025. DOI: 10.14740/jem1055. Disponível em: https://jem.elmerpub.com/jem/article/view/1528.. Acesso em: 20 oct. 2025.